Historical Valuation
Autonomix Medical Inc (AMIX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.49. The fair price of Autonomix Medical Inc (AMIX) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.51
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Autonomix Medical Inc (AMIX) has a current Price-to-Book (P/B) ratio of 0.52. Compared to its 3-year average P/B ratio of 0.92 , the current P/B ratio is approximately -44.07% higher. Relative to its 5-year average P/B ratio of 0.92, the current P/B ratio is about -44.07% higher. Autonomix Medical Inc (AMIX) has a Forward Free Cash Flow (FCF) yield of approximately -302.96%. Compared to its 3-year average FCF yield of -120.54%, the current FCF yield is approximately 151.33% lower. Relative to its 5-year average FCF yield of -120.54% , the current FCF yield is about 151.33% lower.
P/B
Median3y
0.92
Median5y
0.92
FCF Yield
Median3y
-120.54
Median5y
-120.54
Competitors Valuation Multiple
AI Analysis for AMIX
The average P/S ratio for AMIX competitors is 0.26, providing a benchmark for relative valuation. Autonomix Medical Inc Corp (AMIX.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for AMIX
1Y
3Y
5Y
Market capitalization of AMIX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AMIX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AMIX currently overvalued or undervalued?
Autonomix Medical Inc (AMIX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.49. The fair price of Autonomix Medical Inc (AMIX) is between to according to relative valuation methord.
What is Autonomix Medical Inc (AMIX) fair value?
AMIX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Autonomix Medical Inc (AMIX) is between to according to relative valuation methord.
How does AMIX's valuation metrics compare to the industry average?
The average P/S ratio for AMIX's competitors is 0.26, providing a benchmark for relative valuation. Autonomix Medical Inc Corp (AMIX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Autonomix Medical Inc (AMIX) as of Jan 10 2026?
As of Jan 10 2026, Autonomix Medical Inc (AMIX) has a P/B ratio of 0.52. This indicates that the market values AMIX at 0.52 times its book value.
What is the current FCF Yield for Autonomix Medical Inc (AMIX) as of Jan 10 2026?
As of Jan 10 2026, Autonomix Medical Inc (AMIX) has a FCF Yield of -302.96%. This means that for every dollar of Autonomix Medical Inc’s market capitalization, the company generates -302.96 cents in free cash flow.
What is the current Forward P/E ratio for Autonomix Medical Inc (AMIX) as of Jan 10 2026?
As of Jan 10 2026, Autonomix Medical Inc (AMIX) has a Forward P/E ratio of -0.28. This means the market is willing to pay $-0.28 for every dollar of Autonomix Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Autonomix Medical Inc (AMIX) as of Jan 10 2026?
As of Jan 10 2026, Autonomix Medical Inc (AMIX) has a Forward P/S ratio of 0.00. This means the market is valuing AMIX at $0.00 for every dollar of expected revenue over the next 12 months.